Original Research
Accepted on 30 Jan 2025
Low-level neurostimulation of the renal nerves as a potential therapeutic strategy for hypertension treatment
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1529844
Type at least 3 characters
2,301 articles
Articles
Original Research
Published on 30 Jan 2025
FAM134B-mediated endoplasmic reticulum autophagy protects against cisplatin-induced spiral ganglion neuron damage
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1462421
Systematic Review
Accepted on 29 Jan 2025
New options for cilostazol-based dual antiplatelet therapy for ischaemic stroke prevention in East Asian populations: a systematic review and meta-analysis
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1533674
Systematic Review
Published on 29 Jan 2025
Systematic review and meta-analysis of propranolol in the prevention and treatment of post-traumatic stress disorder
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1545493
- 105 views
Correction
Published on 29 Jan 2025
Corrigendum: Polydatin ameliorates early brain injury after subarachnoid hemorrhage through up-regulating SIRT1 to suppress endoplasmic reticulum stress
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1537295
Original Research
Accepted on 28 Jan 2025
The effect of cannabinoid type Ⅱ receptor on the excitability of substantia nigra dopaminergic neurons
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1522210
Editorial
Accepted on 28 Jan 2025
'Editorial: The Mechanistic Investigation and Emerging Therapies for Friedreich's Ataxia'
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1560808
Review
Accepted on 28 Jan 2025
Neurotoxicity Mechanisms and Clinical Implications of Six Common Recreational Drugs
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1526270
Original Research
Accepted on 27 Jan 2025
Methamphetamine Self-Administration Causes Neuronal Dysfunction in Rat Medial Prefrontal Cortex in a Sex-Specific and Withdrawal Time-Dependent Manner
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1527795
Original Research
Accepted on 27 Jan 2025
Reversal of anxiety-like depression induced by chronic corticosterone by crocin I and surface-enhanced Raman spectroscopy monitoring of plasma metabolites
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1540551
Original Research
Published on 27 Jan 2025
Following intravenous thrombolysis, the outcome of diabetes mellitus associated with acute ischemic stroke was predicted via machine learning
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1506771
- 219 views
Review
Published on 27 Jan 2025
Trends in research on novel antidepressant treatments
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1544795
- 274 views
Original Research
Published on 27 Jan 2025
Enhanced bioavailability of Quercetin-loaded niosomal in situ gel for the management of Parkinson’s disease
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1519649
- 252 views
Original Research
Published on 23 Jan 2025
αAsarone alleviates neuronal injury by facilitating autophagy via miR-499-5p/PDCD4/ATG5 signaling pathway in ischemia stroke
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1504683
- 220 views
Original Research
Published on 23 Jan 2025
Trazodone effectiveness in depression: impacts of trazodone extended release vs SSRIs on the health status and quality of life of patients with major depressive disorder
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1525498
- 249 views
Original Research
Published on 23 Jan 2025
Real-world pharmacovigilance of ofatumumab in multiple sclerosis: a comprehensive FAERS data analysis
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1521726
- 297 views